ストックスクリーナーアプリを入手
3.6101
17.77%
-0.7799
アフターアワーズ：
4.03
0.4199
+11.63%
前日終値:
$4.39
開ける：
$4.175
24時間の取引高:
23,794
Relative Volume:
1.03
時価総額：
$5.37M
収益：
$27.40M
当期純損益:
$-17.12M
株価収益率:
-0.0338
EPS:
-106.8896
ネットキャッシュフロー:
$-24.99M
1週間 パフォーマンス:
+19.15%
1か月 パフォーマンス:
+11.77%
6か月 パフォーマンス:
+24.49%
1年 パフォーマンス:
-69.61%
1日の値動き範囲:
$3.6101
$4.175
1週間の範囲:
$2.9456
$4.48
52週間の値動き範囲:
$2.5211
$16.97
Dna X Inc Stock (SONM) Company Profile
Compare SONM vs MSFT, PLTR, ORCL, CRWD, FTNT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
SONM
Dna X Inc
|
3.6101 | 6.53M | 27.40M | -17.12M | -24.99M | -106.89 |
MSFT
Microsoft Corp
|
500.59 | 3.70T | 318.27B | 125.22B | 72.92B | 16.79 |
PLTR
Palantir Technologies Inc
|
191.79 | 444.54B | 5.22B | 2.29B | 2.69B | 0.8876 |
ORCL
Oracle Corp
|
144.56 | 451.14B | 67.36B | 17.31B | -23.69B | 5.8248 |
CRWD
Crowdstrike Holdings Inc
|
262.49 | 256.05B | 5.09B | -24.89M | 1.43B | -0.0471 |
FTNT
Fortinet Inc
|
178.74 | 127.86B | 7.11B | 1.95B | 2.44B | 2.5883 |
Dna X Inc Stock (SONM) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2019-10-31 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2019-07-18 | 開始されました | B. Riley FBR | Buy |
| 2019-07-09 | アップグレード | National Securities | Neutral → Buy |
| 2019-06-10 | 開始されました | National Securities | Neutral |
| 2019-06-04 | 開始されました | Lake Street | Buy |
| 2019-06-04 | 開始されました | Oppenheimer | Outperform |
すべてを表示
Dna X Inc (SONM) 最新ニュース
VEON Ltd. (VEON) Stock Price, News, Quote & History - Yahoo! Finance Canada
VEON Ltd. (VEON) stock price, news, quote and history - Yahoo Finance UK
X-Chem Announces Phase 3 Milestone in Collaboration with Relay Therapeutics - Yahoo Finance
How DNA's Double Helix Structure Was Discovered - Britannica
Press Release Service: Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform - CRISPR Medicine News
Sonim Technologies Maintains Nasdaq Compliance Amid Monitoring Period - The Globe and Mail
DNA regained Nasdaq equity compliance but faces one-year mandatory monitor - TradingView
SONM Q3 2024 Earnings: Loss Narrower Than Expected, Shares Rise 5.8%Profit Recovery Report - vinanet.vn
Sonim Technologies Adopts Cash-Based Director Compensation Structure - The Globe and Mail
DNA awards Substitute Cash Grants to board including CEO Mike Mulica - TradingView
DNA X (SONM) turns to cash after equity plan runs out of shares - Stock Titan
Restriction-enzyme DNA fingerprinting method explained - britannica.com
Ginkgo Bioworks (DNA) CFO logs 743 RSU vesting, tax sale - Stock Titan
DNA X: Q2 Earnings Snapshot - AOL.com
DNA X, Inc. Reports Second Quarter 2026 Financial Results - manilatimes.net
DNA X Q2 EPS improves to $(0.91) from $(14.15) YoY - scanx.trade
DNA X, Inc. 2Q 2026: Revenue $0 EPS $(0.92) — 10-Q Summary - TradingView
SONM: Net income surged to $5.1M as the company pivoted to crypto trading and raised $5M in new capital - TradingView
DNA X (Nasdaq: SONM) profits from phone sale while crypto platform is in the red - Stock Titan
C&F Financial Corporation Announces Quarterly Dividend - The Manila Times
Beam Global Reports Second Quarter 2026 Operating Results - The Manila Times
VVC Exploration Corporation Files Annual Financial Statements - The Manila Times
DNA X raised $5 million after its quarter ended, while its trading platform had no revenue - Stock Titan
DNA (SONM) Quarter in Focus: The Bottom-Line Figure Outpaces Its Comparison in the Latest Session; Market Reaction: The Stock Ends Down 0.60% in Latest TradingGuidance Update - vinanet.vn
12 Information Technology Stocks Moving In Monday's After-Market Session - Benzinga
Aon plc (AON) Holds Near $355.83 as Insurance Broker Consolidates Between Support and ResistanceHigh Volume Node - Vinanet
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Analysts Just Slashed This Year's Revenue Estimates By 22% - simplywall.st
Sonim Technologies delays quarterly filing amid consolidation - TipRanks
DNA X, Inc. (SONM) delays Q2 2026 filing but projects smaller net loss - Stock Titan
SONM Q2'26 Earnings: EPS estimate is 5.22 USD - TradingView
Creative Realities, Inc. (CREX) Stock Price, News, Quote & History - finance.yahoo.com
DNA X, Inc. (SONM) raises $2.5M and targets Nasdaq equity rule compliance - Stock Titan
DNA X, Inc. (SONM) investor Lytton discloses 6.8% stake in latest 13G/A - Stock Titan
DNA X Inc. (SONM) Holds Flat at $3.56 as Range-Bound Trading PersistsChannel Breakout - vinanet.vn
Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination - Yahoo Finance
Star Wars Zero Company is a very safe XCOM descendant, but its most interesting parts are found in its Midnight Suns DNA - PC Gamer
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) Shares Slammed 36% But Getting In Cheap Might Be Difficult Regardless - 富途牛牛
SONM Q3 2024 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesEarnings Beat Streak - dars.gov.et
Ginkgo Bioworks Holdings, Inc. 2026 Q2ResultsEarnings Call Presentation (NYSE:DNA) 2026-08-06 - Seeking Alpha
DNA X Inc. (SONM) Slips 1.69% as Shares Test Key Support at $3.60Channel Projection - dars.gov.et
Token Talk Inc. (DNAX) stock price, news, quote and history - Yahoo Finance UK
Ginkgo Bioworks (NYSE: DNA) plans Q2 2026 results presentation and Q&A - Stock Titan
Ginkgo Bioworks (NYSE: DNA) awards RSUs to 10% owner - Stock Titan
DNA X, Inc. Revenue Breakdown – NASDAQ:SONM - TradingView
YD Bio and EG BioMed Conclude Successful Exhibition at BIO Asia-Taiwan 2026, Highlighting Innovations in Ophthalmology, Oncology Diagnostics, and Clinical Services - The Manila Times
12 Information Technology Stocks Moving In Monday's Pre-Market Session - Benzinga
DNA Sequencing Market Size to Hit USD 57.39 Billion by 2035 - Precedence Research
SAY Q2 2026 Earnings: Significant EPS Miss Raises ConcernsEstimate Uncertainty - dars.gov.et
Sonim Technologies Strengthens Capital Structure With Preferred Financing - The Globe and Mail
12 Information Technology Stocks Moving In Thursday's After-Market Session - Benzinga
DNA X, Inc. Enters Securities Purchase Agreement and Designates Series B Preferred Stock in Major 2026 Transaction - Minichart
Dna X Inc (SONM) 財務データ
収益
当期純利益
現金流量
EPS
3.68%
0.16%
大文字化:
|
ボリューム (24 時間):